RUNX3 Suppresses Migration, Invasion and Angiogenesis of Human Renal Cell Carcinoma
Open Access
- 14 February 2013
- journal article
- biology
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2), e56241
- https://doi.org/10.1371/journal.pone.0056241
Abstract
RUNX3 (runt-related transcription factor-3) is a known tumor suppressor gene which exhibits potent antitumor activity in several carcinomas. However, little is known about the role of RUNX3 in human renal cell carcinoma (RCC). To investigate the clinical relevance of RUNX3 in RCC patients, immunohistochemistry was performed to detect the clinical relevance of RUNX3 in 75 RCC tissues and paired non-cancerous tissues by using tissue microarray (TMA). We also investigated the role of RUNX3 in RCC cell migration, invasion and angiogenesis. The RUNX3 expression was decreased dramatically in human RCC tissue. The RUNX3 expression was significantly correlated with tumor size (PPP<0.001). Restoration of RUNX3 significantly decreased renal carcinoma cell migration and invasion capacity compared with controls. In addition, we found that overexpression of RUNX3 reduced the proliferation and tube formation of human umbilical vascular endothelial cells (HUVECs). Gelatin zymography and Western blot showed that RUNX3 expression suppressed matrix metalloproteinase-9 (MMP-9) protein level and enzyme activity. Western blot and ELISA showed that RUNX3 restoration inhibited the expression and secretion of vascular endothelial growth factor (VEGF). Taken together, our studies indicate that decreased expression of RUNX3 in human RCC tissue is significantly correlated with RCC progression. Restoration of RUNX3 expression significantly inhibits RCC cells migration, invasion and angiogenesis. These findings provide new insights into the significance of RUNX3 in migration, invasion and angiogenesis of RCC.This publication has 26 references indexed in Scilit:
- Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011Australian & New Zealand Journal of Psychiatry, 2012
- Possible Involvement of RUNX3 Silencing in the Peritoneal Metastases of Gastric CancersClinical Cancer Research, 2005
- Matrix metalloproteinases and angiogenesisJournal of Cellular and Molecular Medicine, 2005
- Tumor suppressor activity of RUNX3Oncogene, 2004
- Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinomaLaboratory Investigation, 2004
- Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- Causal Relationship between the Loss of RUNX3 Expression and Gastric CancerCell, 2002
- Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domainGene, 1995
- PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Type beta transforming growth factor: a bifunctional regulator of cellular growth.Proceedings of the National Academy of Sciences of the United States of America, 1985